Literature DB >> 9647011

Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis.

D Provenzale1, J B Wong, J E Onken, J Lipscomb.   

Abstract

OBJECTIVE: To illustrate the principles of cost-effectiveness analysis, this third article in the "Primer on Economic Analysis for the Gastroenterologist" applies published criteria for appraising an economic analysis to a study of the cost-effectiveness of surveillance of patients with ulcerative colitis.
METHODS: We review and apply the 10 standard criteria for critical appraisal and evaluation of cost-effectiveness analyses.
SUMMARY: We outlined the development and critique of a decision analytic model that examines the cost-effectiveness of surveillance of patients with ulcerative colitis, and we compared the cost-effectiveness of surveillance of patients with ulcerative colitis to other well-accepted medical practices.

Entities:  

Mesh:

Year:  1998        PMID: 9647011     DOI: 10.1111/j.1572-0241.1998.00314.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

Review 1.  Inflammatory bowel disease: the problems of dysplasia and surveillance.

Authors:  P J Mitchell; E Salmo; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2007-11-30       Impact factor: 3.781

Review 2.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

3.  Individual health discount rate in patients with ulcerative colitis.

Authors:  Akbar K Waljee; Arden M Morris; Jennifer F Waljee; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2010-11-16       Impact factor: 5.325

4.  Advances in the Diagnosis and Management of Colonic Dysplasia in Patients With Inflammatory Bowel Disease.

Authors:  Shirley Cohen-Mekelburg; Yecheskel Schneider; Stephanie Gold; Ellen Scherl; Adam Steinlauf
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-06

5.  Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view.

Authors:  John B Kisiel; David A Ahlquist
Journal:  Therap Adv Gastroenterol       Date:  2013-09       Impact factor: 4.409

6.  A decision analysis of surveillance for colorectal cancer in ulcerative colitis.

Authors:  F Delcò; A Sonnenberg
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 7.  Colorectal Cancer in Inflammatory Bowel Disease.

Authors:  Ryan W Stidham; Peter D R Higgins
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

8.  Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis.

Authors:  John B Kisiel; Gauree G Konijeti; Andrew J Piscitello; Tarun Chandra; Thomas F Goss; David A Ahlquist; Francis A Farraye; Ashwin N Ananthakrishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2016-07-25       Impact factor: 11.382

9.  Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates.

Authors:  Joel H Rubenstein; Akbar K Waljee; Joanne M Jeter; Fernando S Velayos; Uri Ladabaum; Peter D R Higgins
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

10.  Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

Authors:  Roopali Bansal Gupta; Noam Harpaz; Steven Itzkowitz; Sabera Hossain; Sierra Matula; Asher Kornbluth; Carol Bodian; Thomas Ullman
Journal:  Gastroenterology       Date:  2007-08-02       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.